glp 1 agonist companies GLP-1s & Beyond: Understanding Incretin Mimetic Opportunities GLP-1 agonists market to reach

Rossing, M.L

doi: 10.2337/diacare.21.9.1414 4 WhitingDRGuariguataLWeilCShawJ

I have to say after a little bit of an adjustment period you can really feel this stuff working

The researchers analyzed thousands of electronic medical records of older adults with both diabetes and cancer and found that those who were taking GLP-1s had lower all-cause mortality than did those who were taking another type of diabetes medication, dipeptidyl peptidase 4 inhibitors (DPP-4i)

A phase 1b randomised controlled trial of a glucagon-like peptide-1 and glucagon receptor dual agonist IBI362 (LY3305677) in Chinese patients with type 2 diabetes

The clinical trial evidence on duration The landmark STEP trials for semaglutide and SURMOUNT trials for tirzepatide provide the clearest data on what happens at different treatment durations